Business
Pfizer, BioNTech warn UK against plans to delay second vaccine jab – Sydney Morning Herald
Health authorities across the world are debating the wisdom of delaying the second shot for three months to make scarce supplies go further.
Many experts have supported the decision to delay the second jab so that more people can get the first given the gravity of the UK’s rapidly worsening second wave. But others such as US infectious diseases chief Anthony Fauci have criticised the dosing regime because it was not tested in clinical trials.
In a joint statement released on Monday, Germany drug company BioNTech and its American partner Pfizer said there was “no data” to demonstrate that the protection offered by the first dose would…
-
Noosa News18 hours agoPill checking to resume in Queensland months after government axed funding
-
Business21 hours agoWhy Austal, Boss Energy, Harvey Norman, and NextDC shares are charging higher today
-
Business22 hours agoASX shares are expensive. Here’s why you should be buying anyway
-
Business20 hours agoBrokers name 3 ASX shares to buy today 29 August 2025